(AVNT) Avient - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US05368V1061
AVNT: Color Concentrates, Additives, Inks, Polymer Formulations
Avient Corporation, listed on the NYSE as AVNT, stands as a leader in material solutions, offering a diverse portfolio that caters to a wide array of industries. Their expertise lies in formulation, with a strong emphasis on innovation and sustainability, which are crucial in todays market.
The company operates through two key segments: Color, Additives and Inks, and Specialty Engineered Materials. The former provides custom color and additive solutions, enhancing both aesthetics and functionality in plastics. This segment serves industries ranging from healthcare to consumer goods, highlighting their versatility. The latter focuses on advanced polymers, delivering tailored solutions for thermoplastic applications, which are essential in automotive and electronics sectors.
With a market cap of approximately $3.9 billion, Avient demonstrates a robust financial standing. Their trailing P/E of 23.34 and forward P/E of 15.11 suggest a valuation that reflects their growth prospects. The price-to-book ratio of 1.70 indicates a modest premium, aligning with their industry peers. Their price-to-sales ratio of 1.22 underscores efficient revenue generation relative to their market value.
Avients strategic rebranding from PolyOne in 2020 signifies a shift towards a more innovative and sustainable identity. Their R&D investments and global expansion into emerging markets position them well for future growth. Investors may find their exposure to high-growth sectors and commitment to eco-friendly materials particularly appealing, making Avient a notable player in the specialty chemicals industry.
Additional Sources for AVNT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AVNT Stock Overview
Market Cap in USD | 3,401m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception | 1999-09-13 |
AVNT Stock Ratings
Growth 5y | 33.8% |
Fundamental | -10.5% |
Dividend | 59.5% |
Rel. Strength | -5.43 |
Analysts | 4.14/5 |
Fair Price Momentum | 36.07 USD |
Fair Price DCF | 31.97 USD |
AVNT Dividends
Dividend Yield 12m | 2.59% |
Yield on Cost 5y | 6.16% |
Annual Growth 5y | 4.90% |
Payout Consistency | 70.0% |
AVNT Growth Ratios
Growth Correlation 3m | -29.1% |
Growth Correlation 12m | -12.9% |
Growth Correlation 5y | 25.6% |
CAGR 5y | 17.16% |
CAGR/Max DD 5y | 0.32 |
Sharpe Ratio 12m | -0.66 |
Alpha | -23.11 |
Beta | 1.449 |
Volatility | 33.04% |
Current Volume | 595.5k |
Average Volume 20d | 598k |
As of April 03, 2025, the stock is trading at USD 37.87 with a total of 595,520 shares traded.
Over the past week, the price has changed by -3.47%, over one month by -7.54%, over three months by -5.31% and over the past year by -9.15%.
Neither. Based on ValueRay Fundamental Analyses, Avient is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -10.51 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AVNT as of April 2025 is 36.07. This means that AVNT is currently overvalued and has a potential downside of -4.75%.
Avient has received a consensus analysts rating of 4.14. Therefor, it is recommend to buy AVNT.
- Strong Buy: 4
- Buy: 0
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, AVNT Avient will be worth about 40.2 in April 2026. The stock is currently trading at 37.87. This means that the stock has a potential upside of +6.18%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 54.1 | 43% |
Analysts Target Price | 59 | 55.8% |
ValueRay Target Price | 40.2 | 6.2% |